WallStreetZenWallStreetZen

NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for RCKT

Based on 6 analysts offering 12 month price targets for Rocket Pharmaceuticals Inc.
Min Forecast
$39.00+71.58%
Avg Forecast
$54.33+139.04%
Max Forecast
$65.00+185.97%

Should I buy or sell RCKT stock?

Based on 6 analysts offering ratings for Rocket Pharmaceuticals Inc.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
1 analysts 16.67%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RCKT stock forecasts and price targets.

RCKT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-07
lockedlocked$00.00+00.00%2024-04-02
lockedlocked$00.00+00.00%2024-03-01
lockedlocked$00.00+00.00%2024-02-27
lockedlocked$00.00+00.00%2024-02-27
Cantor Fitzgerald
Top 8%
93
Strong BuyReiterates$65.00+185.97%2024-01-31

1 of 1

Forecast return on equity

Is RCKT forecast to generate an efficient return?
Company
N/A
Industry
76.1%
Market
79%

Forecast return on assets

Is RCKT forecast to generate an efficient return on assets?
Company
N/A
Industry
30.96%

RCKT earnings per share forecast

What is RCKT's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$2.85
Avg 2 year Forecast
-$2.01
Avg 3 year Forecast
$0.58

RCKT revenue forecast

What is RCKT's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$26.0M
Avg 2 year Forecast
$171.1M
Avg 3 year Forecast
$482.2M

RCKT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RCKT$22.73$54.33+139.04%Strong Buy
VERA$38.00$45.67+20.18%Strong Buy
IMCR$40.53$82.38+103.24%Strong Buy
VCEL$43.52$54.50+25.23%Strong Buy
KYMR$34.60$45.75+32.23%Strong Buy

Rocket Pharmaceuticals Stock Forecast FAQ

Is Rocket Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: RCKT) stock is to Strong Buy RCKT stock.

Out of 6 analysts, 4 (66.67%) are recommending RCKT as a Strong Buy, 1 (16.67%) are recommending RCKT as a Buy, 1 (16.67%) are recommending RCKT as a Hold, 0 (0%) are recommending RCKT as a Sell, and 0 (0%) are recommending RCKT as a Strong Sell.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.

What is RCKT's earnings growth forecast for 2024-2026?

(NASDAQ: RCKT) Rocket Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.61%.

Rocket Pharmaceuticals's earnings in 2024 is -$249,314,000.On average, 8 Wall Street analysts forecast RCKT's earnings for 2024 to be -$258,393,407, with the lowest RCKT earnings forecast at -$300,489,118, and the highest RCKT earnings forecast at -$153,421,937. On average, 6 Wall Street analysts forecast RCKT's earnings for 2025 to be -$182,771,825, with the lowest RCKT earnings forecast at -$274,162,277, and the highest RCKT earnings forecast at -$49,022,394.

In 2026, RCKT is forecast to generate $52,199,771 in earnings, with the lowest earnings forecast at -$112,569,942 and the highest earnings forecast at $216,969,484.

What is RCKT's revenue growth forecast for 2024-2026?

(NASDAQ: RCKT) Rocket Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Rocket Pharmaceuticals's revenue in 2024 is $0.On average, 5 Wall Street analysts forecast RCKT's revenue for 2024 to be $2,363,605,646, with the lowest RCKT revenue forecast at $72,625,769, and the highest RCKT revenue forecast at $9,023,751,773. On average, 5 Wall Street analysts forecast RCKT's revenue for 2025 to be $15,533,653,342, with the lowest RCKT revenue forecast at $2,097,069,074, and the highest RCKT revenue forecast at $26,435,779,843.

In 2026, RCKT is forecast to generate $43,777,724,046 in revenue, with the lowest revenue forecast at $23,478,095,409 and the highest revenue forecast at $64,077,352,683.

What is RCKT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RCKT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 30.96%.

What is RCKT's Price Target?

According to 6 Wall Street analysts that have issued a 1 year RCKT price target, the average RCKT price target is $54.33, with the highest RCKT stock price forecast at $65.00 and the lowest RCKT stock price forecast at $39.00.

On average, Wall Street analysts predict that Rocket Pharmaceuticals's share price could reach $54.33 by May 7, 2025. The average Rocket Pharmaceuticals stock price prediction forecasts a potential upside of 139.04% from the current RCKT share price of $22.73.

What is RCKT's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: RCKT) Rocket Pharmaceuticals's current Earnings Per Share (EPS) is -$2.85. On average, analysts forecast that RCKT's EPS will be -$2.85 for 2024, with the lowest EPS forecast at -$3.31, and the highest EPS forecast at -$1.69. On average, analysts forecast that RCKT's EPS will be -$2.01 for 2025, with the lowest EPS forecast at -$3.02, and the highest EPS forecast at -$0.54. In 2026, RCKT's EPS is forecast to hit $0.58 (min: -$1.24, max: $2.39).

What is RCKT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RCKT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.